HbA1c screening for the diagnosis of diabetes

Autoři: Ing. Marek Brabec, PhD.
Rok vydání: 2023
Typ publikace: Článek v odborném periodiku
Periodikum: Diabetologia
Bibliografická citace: BROŽ, J., BRABEC, Marek, KROLLOVÁ, P., FAČKOVCOVÁ, L., MICHALEC, J. HbA1c screening for the diagnosis of diabetes. Diabetologia. 2023, 66(8), 1576-1577. ISSN 0012-186X. E-ISSN 1432-0428
Dostupné z: doi:10.1007/s00125-023-05924-5.
DOI: 10.1007/s00125-023-05924-5
ID: 573030
Online záznam: Zobrazit online záznam

Abstrakt

We read with great interest the study by Young et al [1] on the impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults. Based on HbA1c levels among UK Biobank participants aged 40–70 years, 1% of 166,846 participants were found to have undiagnosed diabetes. The median time to clinical diagnosis for those with undiagnosed diabetes was 2.2 years.